RESPONSE 2: REsting and Stimulus-based Paradigms to Detect Organized NetworkS and Predict Emergence of Consciousness

Sponsor
Massachusetts General Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT03504709
Collaborator
(none)
75
1
109.9
0.7

Study Details

Study Description

Brief Summary

The aim of this study is to assess the utility of advanced magnetic resonance imaging (MRI) and electroencephalographic (EEG) technologies for predicting functional outcomes in patients with severe traumatic brain injury (TBI).

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    75 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Advanced MRI and EEG to Predict Recovery of Consciousness After Severe Traumatic Brain Injury
    Actual Study Start Date :
    Sep 5, 2018
    Anticipated Primary Completion Date :
    Sep 5, 2022
    Anticipated Study Completion Date :
    Nov 1, 2027

    Arms and Interventions

    Arm Intervention/Treatment
    Patient (n=50)

    Adults with acute severe traumatic brain injury who undergo advanced neuroimaging and electrophysiological studies while in the intensive care unit and are followed for 6 months post injury.

    Healthy (n=25)

    Healthy adults with no neurological, psychiatric, or medical disease.

    Outcome Measures

    Primary Outcome Measures

    1. Disability Rating Scale total score [6 months post injury]

      The Disability Rating Scale (DRS) provides quantitative information regarding functional disability in patients recovering from severe brain injury. The total score on the DRS ranges from 0 to 29 with higher scores indicating a greater degree of disability. DRS subscale scores include eye opening [score range 0-3], communication [score range 0-4], motor response [score range 0-5], cognitive ability for feeding [score range 0-3], cognitive ability for toileting [score range 0-3], cognitive ability for grooming [score range 0-3], level of function [score range 0-5], and employability [score range 0-3]. Subscale scores are summed to produce the total score.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Patients:
    Inclusion Criteria:
    • Traumatic Brain Injury

    • Glasgow Coma Scale score of 3-8 within 24 hours, unconfounded by sedation, paralysis, hypoxia, hypotension, hypothermia, or concurrent medical illness

    • Clinical evidence of disorder of consciousness defined as coma, VS, or MCS

    Exclusion Criteria:
    • History of prior severe brain injury or dementia

    • Emergence from MCS at time of initial CRS-R assessment

    Healthy Subjects:
    Exclusion Criteria:

    History of brain injury or neurological disease, psychiatric disease, or any history of diabetes, high blood pressure, heart disease, or kidney disease

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Massachusetts General Hospital Boston Massachusetts United States 02114

    Sponsors and Collaborators

    • Massachusetts General Hospital

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Brian L. Edlow, M.D., Neurocritical Care Faculty, Massachusetts General Hospital, Associate Director, Center for Neurotechnology and Neurorecovery (CNTR) Director, Laboratory for NeuroImaging of Coma and Consciousness (NICC), Massachusetts General Hospital
    ClinicalTrials.gov Identifier:
    NCT03504709
    Other Study ID Numbers:
    • 2012P000784
    First Posted:
    Apr 20, 2018
    Last Update Posted:
    Apr 5, 2022
    Last Verified:
    Apr 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 5, 2022